Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

79
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
79
Brainstem01:19

Brainstem

3.7K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

887
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
887
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

469
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
469
Neural Regulation01:37

Neural Regulation

40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortical GABAergic dysfunction underlying abnormal hand movements in ARX mutation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019
Same author

Gelastic Cataplexy in Niemann Pick Type C.

Movement disorders clinical practice·2019
Same author

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Molecular neurobiology·2019
Same author

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology·2019
Same author

Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2019
Same author

Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis.

Parkinsonism & related disorders·2019

Related Experiment Video

Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K

Parkinson's disease.

Lorraine V Kalia1, Anthony E Lang1

  • 1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Lancet (London, England)
|April 24, 2015
PubMed
Summary

Parkinson's disease (PD) presents complex motor and non-motor symptoms, pathology, and unknown causes. Current treatments manage symptoms but do not slow neurodegeneration, highlighting significant clinical challenges.

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

Related Experiment Videos

Last Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Parkinson's disease (PD) is traditionally defined by motor symptoms, Lewy bodies, and substantia nigra neuron loss.
  • Recent understanding reveals PD's heterogeneity, encompassing significant non-motor features and widespread pathology beyond Lewy bodies.
  • The etiology of PD is multifactorial, involving a complex interaction between genetic and environmental factors impacting cellular processes.

Purpose of the Study:

  • To review the evolving complexities of Parkinson's disease.
  • To discuss the clinical challenges associated with Parkinson's disease diagnosis and management.
  • To highlight the limitations of current therapeutic approaches for Parkinson's disease.

Main Methods:

  • Literature review of Parkinson's disease.
  • Analysis of current understanding of PD symptomatology and pathology.
  • Examination of diagnostic and therapeutic challenges in Parkinson's disease.

Main Results:

  • Parkinson's disease exhibits heterogeneous motor and non-motor symptoms.
  • Pathology extends beyond the substantia nigra, involving multiple neurotransmitters and protein aggregates.
  • Early diagnosis and effective symptom management remain challenging, with no disease-modifying treatments available.

Conclusions:

  • Parkinson's disease is a complex neurological disorder with multifaceted pathology and symptomatology.
  • Significant clinical challenges exist in early diagnosis, symptom management, and the lack of neuroprotective therapies.
  • Further research is needed to unravel the complexities of PD and develop effective treatments.